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Abstract 
Regulation of XIAP by GSK3 during Wnt signaling 
The Wnt signaling pathway plays essential roles in a wide variety of biological processes 
including early animal development, cell fate determination, cell proliferation, organogenesis, and 
stem-cell renewal. Deregulation of the Wnt pathway can lead to human disease (e.g. 
developmental defects and cancers). Our lab had previously demonstrated that X-linked Inhibitor 
of Apoptosis (XIAP) is required for Wnt signaling via a mechanism that involves XIAP-facilitated 
dissociation of Gro/TLE from TCF/Lef. We had shown that XIAP is recruited onto TCF/Lef 
complexes upon Wnt pathway activation and ubiquitinates Gro/TLE-bound TCF/Lef. 
Ubiquitinated Gro/TLE has decreased affinity for TCF/Lef, allowing beta-catenin to bind. The 
mechanism by which XIAP is recruited onto TCF/Lef is not known. 
We found that XIAP is phosphorylated by GSK3, a known component of the Wnt pathway. 
Using mass spectrometry analysis with purified proteins, we identified two GSK3 phosphorylation 
sites on XIAP that are strongly phosphorylated. Mutational analysis of these two sites indicate that 
they are required by XIAP to fully activate Wnt signaling, as assessed by reporter assays in 
cultured mammalian cells and axis duplication assays in Xenopus embryos. Using purified 
proteins, we found that the XIAP phosphomutants have similar ubiquitination activity as wild-type 
XIAP. In cultured mammalian cells, however, the XIAP phosphomutants have a markedly 
decreased capacity to ubiquitinate Gro/TLE. We also showed that the phosphomutants also have 
a decreased affinity for Gro/TLE. 
We propose a model in which phosphorylation is required for the interaction between XIAP 
and Gro/TLE to activate Wnt signaling. GSK3 phosphorylates XIAP at T180 and S239 to facilitate 
 ix 
its binding to Gro/TLE. XIAP can then ubiquitinate and remove Gro/TLE for subsequent binding 
of beta-catenin to form the transcriptionally active complex. 
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Chapter I: Wnt signaling and XIAP 
 Introduction 
The Wnt signaling pathway plays an integral role in cell fate determination, embryonic 
development, cell proliferation, and adult tissue homeostasis. Misregulation of the pathway can 
lead to developmental defects and cancers in humans (Saito-Diaz, Chen et al. 2013). 
Wnt proteins comprise a family of nineteen secreted glycoproteins that act as ligands that 
activate Wnt signaling (Komekado, Yamamoto et al. 2007). They are found in all metazoans from 
fruit flies to humans. Studies of the Wnt signaling pathway was initiated in the 1970s by Sharma 
and Chopra with the characterization of a Drosophila mutation that interfered with wing and 
haltere development leading to reduced or absent wings (Sharma and Chopra 1976). Based on the 
phenotype, the mutation was named “wingless” (wg). Further research by Wieschaus and 
Nusslein-Volhard found that wg played a fundamental role (e.g., segment polarity) in establishing 
the animal body plan (Nüsslein-Volhard and Wieschaus 1980). Subsequently, Nusse and Varmus 
performed a forward genetic screen to identify genes that could induce tumors in mice. Using the 
mouse mammary tumor virus (MMTV) to introduce insertions into the mouse genome, they 
identified integration 1 (int-1), a locus whose disruption led to mammary tumorigenesis (Nusse, 
van Ooyen et al. 1984).  
A cluster of cells called the Spemann organizer is responsible for patterning the body axis 
during Xenopus development (Spemann and Mangold 1924). Likewise, in zebrafish and chick, the 
analogous structures are the embryonic shield and Hensen’s node, respectively. These organizing 
regions represent important centers of induction that establish cell fate and the body plan during 
early animal development. In the Xenopus embryo, Wnt signaling is critical in the formation of 
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the Spemann organizer, which is formed on the future dorsum of the Xenopus embryo. Studies by 
Moon and McMahon showed that Int-1 mRNA injected into the ventral side of Xenopus embryos 
induced the formation of a second Spemann organizer, indicating that Wnt signaling played a 
critical role in organizer formation (McMahon and Moon 1989).  Xenopus embryos injected with 
int-1 mRNA ultimately developed duplication of the dorsal axis and bifurcation of the neural plate, 
further demonstrating the importance of Int-1 in patterning vertebrate embryos. The recognition 
that wg is the Drosophila homolog of int-1 ultimately led to their simplification to Wnt. 
These early discoveries revealed a central role of Wnt signaling in body patterning during 
development, and also suggested its potential role in oncogenesis (Polakis 2010). It is not 
surprising that Wnt signaling plays such an important role in animal development, given that its 
appearance accompanied the evolution of multi-cellular organisms. Consistent with this idea, 
genetic studies have shown that Wnt proteins appear to have undergone multiple rounds of 
duplication and differentiation, corresponding to an increase in the complexity of body plan during 
metazoan evolution. 
The current model of the Wnt pathway 
Wnt pathway activation can be simply described as the translocation of cytoplasmic beta-
catenin (initially identified as the segment polarity gene armadillo in Drosophila) to the nucleus, 
where it can affect the transcription of Wnt-target genes. In the absence of a Wnt signal, beta-
catenin is continuously synthesized and degraded by the beta-catenin destruction complex, which 
is composed of the scaffold proteins Axin and adenomatous polyposis coli (APC), and the kinases 
glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1) (Kimelman and Xu 2006). Upon 
binding of Wnt ligands to co-receptors Frizzled and LRP6, the activity of the beta-catenin 
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destruction complex is inhibited, thereby blocking the degradation of beta-catenin and allowing its 
accumulation in the cytoplasm. Accumulated beta-catenin then enters the nucleus to mediate 
transcription. Thus, Wnt pathway activation can be broadly divided into three distinct steps: 1) 
surface receptor activation, 2) inhibition of the beta-catenin destruction complex, and 3) formation 
of the beta-catenin co-activator complex initiating the transcription of Wnt-target genes. 
Surface receptor activation 
Wnt ligands are a family of secreted, lipid-modified cysteine-rich glycoproteins approximately 
350-400 amino acids in length. In vertebrates, 19 Wnt ligands have been identified (Janda, 
Waghray et al. 2012). Post-translational modification of Wnt ligands plays important roles in their 
secretion and activity. N-glycosylation of Wnt ligands is crucial in the release of Wnt ligands from 
cells, and mutations that affect its glycosylation have been shown to block Wnt secretion 
(Komekado, Yamamoto et al. 2007). Wnt ligands have also been shown to undergo acylation with 
palmitate, which is required for their secretion and binding to Frizzled receptors (Willert, Brown 
et al. 2003). Palmitoylation of Wnt ligands occurs in the endoplasmic reticulum by the 
transmembrane O-acetyltranferase protein Porcupine (Port and Basler 2010). Loss of function 
Porcupine leads to the accumulation of Wnt ligands in the ER (Kadowaki, Wilder et al. 1996). 
Once palmitoylated, Wnt ligands pass through the trans-Golgi network where they bind Wntless 
(WI) and are transported to the plasma membrane for extracellular release.  
Wnt ligands are capable of both short-range and long-range (morphogen) signaling. When 
released, Wnt ligands have been proposed to traverse through extracellular space via several 
mechanisms. These proposed mechanisms could be tissue-specific and influenced by the condition 
of the extracellular environment. Wnt ligands could travel in tissues by diffusion and interact with 
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cell-surface heparin sulfate proteoglycans (HSPGs), which facilitate the accumulation of 
extracellular ligands (Strigini and Cohen 2000). Many of these HSPG involved in binding Wnt 
ligands are attached to the cell surface by glycosylphosphatidylinositol (GPI) anchors. Another 
mechanism by which Wnt ligands may transverse long distances (characterized extensively in 
Drosophila) involves the internalization and then resecretion of Wnt ligands to establish a signal 
gradient (Pfeiffer, Ricardo et al. 2002). 
The Frizzled (Fz) protein is a family of seven-pass transmembrane domain receptors, which 
share some structural similarity to G-protein-coupled receptors (GCPR) (Bhanot, Brink et al. 
1996). LRP5 and LRP 6 are functionally-redundant single-pass transmembrane proteins that act in 
concert with Fz proteins to bind Wnt ligands (Skarnes, Pinson et al. 2000). Binding of Wnt ligands 
to Fz and LRP5/6 co-receptors results in the production of phosphatidylinositol (4,5)-bisphosphate 
(PIP2) via a mechanism involving the cytoplasmic protein Disheveled, inducing the 
oligomerization and clustering of LRP5/6 (Pan, Choi et al. 2008).  
 Formation of oligomerized, “activated” LRP5/6 promotes the recruitment of Axin and 
associated members of the destruction complex to LRP5/6 (Mao, Wang et al. 2001). This initial 
recruitment of Axin (also known as the “initiation step” of receptor activation) results in 
phosphorylation of the intracellular domain (ICD) of LRP5/6 (Baig-Lewis, Peterson-Nedry et al. 
2007). The ICD of the LRP5/6 receptor contains five PPPSPxS motifs, and each of these motifs is 
sufficient for pathway activation. The five motifs have been shown to act in a cooperative manner 
to mediate downstream signaling (Wolf, Palmby et al. 2007). Two kinases associated with the 
destruction complex, GSK3 and CK1, have been demonstrated to phosphorylate the PPPSPxS 
motifs in a sequential manner. Wnt binding induces phosphorylation by GSK3 and studies have 
also shown that CK1 primes the S/T clusters, outside of the PPPSPxS motif, for phosphorylation 
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by GSK3 (Davidson, Wu et al. 2005). In any case, phosphorylated LRP6 has high affinity for Axin 
and promotes further recruitment of Axin-bound GSK3, which in turn promotes further 
phosphorylation of LRP5/6. This positive feedback step is the “amplification step” in Wnt pathway 
activation. Phosphorylated LRP5/6 is able to directly inhibit GSK3 activity, thereby blocking beta-
catenin phosphorylation and subsequent ubiquitin-mediated degradation by the proteasome.  
Components and function of the beta-catenin destruction complex 
In the absence of a Wnt signal, cytoplasmic levels of beta-catenin are maintained at a low level. 
This occurs through the beta-catenin destruction complex, which phosphorylates and targets beta-
catenin for ubiquitin-mediated degradation by the proteasome. The beta-catenin destruction 
complex is composed of the scaffolding proteins Axin and APC, and the kinases GSK3 and CK1. 
Axin is the critical and limiting component in the destruction complex (Lee, Salic et al. 2003). The 
interaction between Axin and APC, beta-catenin, and GSK3 has been determined at atomic 
resolution by x-ray crystallography (Spink, Polakis et al. 2000). Cellular levels of Axin are 
generally low, and it has been proposed that this serves to separate Wnt from other pathways which 
share common components (e.g. GSK3, CK1, and beta-catenin), thus providing specificity. Axin 
levels have been shown to be highly regulated by PARsylation, which promotes its ubiquitin-
mediated degradation (Huang, Mishina et al. 2009).  
GSK3 is a serine/threonine protein kinase that has been shown to be involved in many different 
signaling pathways (Forde and Dale 2007). While GSK3 has both positive (acting at the level of 
LRP5/6) and negative (acting at the level of the destruction complex) effects on Wnt signaling, 
antagonizing GSK3 activity is central to all current models of Wnt signaling mechanisms. CKI 
consists of a family of serine/threonine kinases. CKI family members have also been shown to be 
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widely involved in other signaling pathways (Price 2006). The CKI family proteins have very 
similar catalytic domains, but differ in their C-terminal non-catalytic tails, which vary in length 
and have been implicated in regulating the catalytic activity of the different isoforms (Price 2006). 
Within the destruction complex, CKI provides the priming phosphorylation of beta-catenin for 
subsequent phosphorylation by GSK3 (Liu, Li et al. 2002).  
The other scaffold protein in the destruction complex is adenomatous polyposis coli (APC), a 
large protein of around 300 kDa. APC is a negative regulator of Wnt signaling and its mutation 
has been identified in familial adenomatous polyposis (FAP), a familial precancerous syndrome 
associated with an extremely high risk (nearly 100%) for colorectal cancer (Kinzler, Nilbert et al. 
1991). APC binds beta-catenin, GSK3, and Axin, and loss of APC leads to elevated levels of beta-
catenin and constitutive Wnt pathway activation. The mechanism of action of APC in the Wnt 
pathway is an area of active research. It has been proposed to inhibit Wnt signaling via several 
distinct mechanisms, including 1) retaining beta-catenin in the nucleus (Hamada and Bienz 2004), 
2) targeting the destruction complex to the cell cortex where E3 ligase for beta-catenin resides 
(Bienz, Yu et al. 1999), and 3) blocking the dephosphorylation of beta-catenin (Su, Fu et al. 2008). 
The continual synthesis and degradation of cytoplasmic beta-catenin can be described as a 
“futile cycle”. Such futile cycles are thought to impart increased sensitivity in response to 
physiological changes (Samoilov, Plyasunov et al. 2005). Axin, the rate-limiting protein in the 
complex, plays a critical role in nucleation of the destruction complex. Binding of beta-catenin in 
the presence of both APC and Axin greatly enhances the phosphorylation of beta-catenin by CKI 
at residue serine 45. This phosphorylation creates a priming site to allow subsequent sequential 
phosphorylation of beta-catenin by GSK3 at residues threonine 41, serine 37, and serine 33 (Amit 
2002). GSK3 has been shown to phosphorylate Axin, increasing its affinity for beta-catenin (Luo, 
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Peterson et al. 2007). CKI and GSK3 have also been shown to phosphorylate APC to increase its 
affinity for beta-catenin.  Enhanced binding of phosphorylated APC to beta-catenin has been 
proposed to facilitate the removal of phosphorylated beta-catenin from Axin in order to allow the 
rebinding of non-phosphorylated beta-catenin to the destruction complex (Su, Fu et al. 2008). 
Thus, in this manner, the destruction complex can rapidly catalyze multiple rounds of beta-catenin 
phosphorylation. The exact timing and order of addition of the components involved in the 
formation of the destruction complex is not well understood. Regardless, beta-catenin, when 
phosphorylated at serine 33 and 37, is recognized by beta-TRCP, a subunit of the SCF ubiquitin 
ligase complex (Jiang and Struhl 1998). Binding to beta-TRCP-SCF catalyzes the 
polyubiquitination of beta-catenin and its subsequent degradation by the proteasome.  
Upon Wnt pathway activation, the beta-catenin destruction complex is inhibited, leading to 
increased levels of cytoplasmic beta-catenin. Various models have been proposed by which 
receptor activation leads to inhibition of beta-catenin degradation. One model posits that Wnt 
activation leads to the dissociation of the components in the beta-catenin destruction complex. A 
possible mechanism is via the action of the GSK3 binding protein (GBP), which has been shown 
to compete with Axin for GSK3 binding (Yost, Farr et al. 1998). Knockout studies of GBP in mice, 
however, do not result in a Wnt phenotype. Another model suggests that the destruction complex 
remains intact and is localized to the Fz/LRP6 receptor, where phospho-LRP6 directly inhibits 
GSK3 activity (Hendriksen, Jansen et al. 2008). A third model proposes that Wnt signaling leads 
to inhibitory phosphorylation of GSK3 at serine 9 that inhibits its kinase activity (Yokoyama and 
Malbon 2007). Another model states that the beta-catenin destruction complex scaffold protein 
Axin is degraded upon Wnt signaling (Cselenyi, Jernigan et al. 2008). Because Axin is the rate-
limiting component of the destruction complex, its degradation is likely to impact beta-catenin 
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turnover. Finally, a fifth model suggests that sequestration of GSK3 into multivesicular bodies 
(MVB) occurs upon Wnt signaling, thereby inhibiting the phosphorylation and degradation of 
beta-catenin by GSK3 (Taelman, Dobrowolski et al. 2010). Multiple lines of evidence support 
these models.  Furthermore, many of these models are not mutually exclusive. Regardless of the 
model, the effect of destruction complex inhibition is the accumulation cytoplasmic beta-catenin 
upon Wnt pathway activation 
Formation of the nuclear co-activator complex  
Translocation of beta-catenin to the nucleus occurs rapidly following the rise of cytoplasmic 
beta-catenin levels upon Wnt activation. The beta-catenin protein does not contain any 
recognizable nuclear localization signal (NLS) and its mechanism of nuclear entry remains 
unclear. Beta-catenin does not utilize classic import factors such as RanGTPase (Fagotto 1996). 
However, the armadillo repeats of beta-catenin are structurally similar to importin-beta HEAT 
repeats and might play a role in interacting with the nuclear pore complex (Kutay 1997). On the 
other hand, it is also possible that Wnt signaling regulates beta-catenin nuclear export as there are 
numerous nuclear proteins shown to interact with beta-catenin and could serve as an anchor for 
nuclear retention (Cong and Varmus 2004).  
In the nucleus, in the absence of Wnt activation, T cell specific factor (TCF) family proteins 
interact with Groucho/transducin-like enhancer (Gro/TLE) to form a co-repressor complex that 
inhibits the transcription of Wnt target genes. There are four mammalian TCF members, namely 
TCF1-4. TCF proteins bind at the DNA consensus sequence CCTTTG(T/A)(T/A), termed Wnt-
responsive elements (WRE). WREs regulate about 300-400 gene collectively (Hatzis, van der Flier 
et al. 2008). Upon Wnt pathway activation, translocated beta-catenin displaces Gro/TLE and binds 
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to TCF, transforming the TCF co-repressor complex to a co-activator complex and promoting the 
transcription of Wnt target genes. The transition from a Wnt co-repressor complex to a co-activator 
complex is facilitated by X-linked inhibitor of apoptosis (XIAP), an E3 ligase that plays an integral 
part in the removal of Gro/TLE to promote the binding of beta-catenin to TCF (described in more 
detail below). 
Transcription via the beta-catenin-TCF complex is facilitated by multiple nuclear factors. 
For example, the B-cell CLL/lymphoma 9 (BCL9) protein binds to TCF and Pygopus (Pygo) 
(Thompson, Townsley et al. 2002). Pygo contains a plant homology domain (PHD) that interacts 
with dimethylated histone 3 lysine 4. It has been postulated that the formation of a core 
transcriptional complex consisting of TCF, beta-catenin, BCL9, and Pygo is required for efficient 
transcription of Wnt target genes (Schwab, Patterson et al. 2007).  
Role of ubiquitination in the Wnt pathway 
Protein turnover represents a major mechanism in virtually all cellular processes. The 
turnover, or their levels and half-lives, of proteins with key cellular functions such as DNA 
replication, cell cycle progression, metabolism and apoptosis are tightly regulated for proper 
cellular function (Ciechanover 2009).  In addition, proteins that are misfolded upon synthesis or 
damaged afterwards need to be targeted for degradation to circumvent disrupting other factors in 
the pathways that they normally participate in. 
In the Wnt pathway, the degradation of beta-catenin plays a central role in controlling Wnt 
pathway activation, and degradation of beta-catenin occurs via the ubiquitin pathway. Ubiquitin is 
a small protein (76 kDa) that is covalently attached to the proteins targeted for proteasomal 
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degradation. Ubiquitin has also been shown to function in conjunction with autophagy, lysosomes, 
and other proteases to carry out regulated degradation of intracellular proteins.  
In addition to regulating protein stability, ubiquitin can also change the activity and/or 
localization of a targeted protein in a process that is often dependent on the type and number of 
ubiquitin linkages employed (Peng, Schwartz et al. 2003). The ubiquitination of proteins is 
initiated via the action of the E1 activating enzyme, which catalyzes the formation of a thioester 
bond between a cysteine on the E1 and the C-terminal glycine of ubiquitin in an ATP-dependent 
manner. The E1 enzyme subsequently catalyzes the transfer of ubiquitin to the active site of the 
E2 conjugating enzyme. Lastly, the E2 catalyzes the transfer of ubiquitin to a lysine residue on the 
target protein in a process facilitated by an E3 ubiquitin ligase. E3 ubiquitin ligases are the 
specificity component of the ubiquitination reaction (Varshavsky 2006). There are hundreds of E3 
ligases, which can be divided into two major families based on the presence of two distinct 
domains: 1) the Really Interesting New Gene (RING) and 2) the Homologous to E6AP Carboxy 
Terminus (HECT) domains (Pickart and Eddins 2004). Ubiquitination of substrates are directly 
catalyzed by HECT E3 ligases, and the ubiquitin is transferred from the E3 to the substrate. For 
RING E3s, the E2- ubiquitin conjugate is bound by the E3 ligase, which indirectly mediates the 
transfer of ubiquitin from the E2 to the substrate lysine. Ubiquitin can be added to the target protein 
in a chain-like fashion (polyubiquitination), or as a single moiety on the target protein 
(monoubiquitination).  There are seven internal lysine residues (K6, 11, 27, 29, 33, 48, 63) present 
in the ubiquitin protein, each of which can be used to form distinct ubiquitin chain linkages that 
confer different functions (Behrends and Harper 2011). For example, beta-catenin is ubiquitinated 
by the SCF beta-TRCP E3 ligase (upon its phosphorylation by GSK3 and CK1) via K48-linked 
polyubiquitin chains, which targets it for degradation via the proteasome pathway (Aberle, Bauer 
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et al. 1997). In addition to SCF beta-TRCP, beta-catenin is regulated by another E3 ligase, c-Cbl, 
in the nucleus. Wnt activation promotes the translocation of c-Cbl to the nucleus where it 
ubiquitinates beta-catenin to inhibit the transcription of Wnt target genes (Chitalia, Shivanna et al. 
2013). In contrast to the negative regulation of beta-catenin by SCF beta-TRCP and c-Cbl, 
ubiquitination of beta-catenin by the EDD E3 ligase promotes beta-catenin stability and nuclear 
translocation. Axin, the rate-limiting component of the destruction complex, has also been shown 
to be degraded in an ubiquitin-mediated fashion. Tankyrase is an poly(ADP-Ribose) polymerase 
that ADP-ribosylates Axin. The poly(ADP-ribose) moiety on Axin is recognized by RNF146, a 
poly(ADP-ribose)-directed E3 ligase, that ubiquitinates Axin and targets it for degradation (Huang, 
Mishina et al. 2009). The Wnt pathway protein, Disheveled, has also been shown to be 
ubiquitinated by the E3 ligases NEDD4L and KLHL12, increasing its turnover, decreasing its 
steady-state levels, and inhibiting Wnt signaling (Huang, Langelotz et al. 2009). Recently, the 
transmembrane RING E3 ligases, zinc and ring finger 3 and ring finger 43 (ZNRF3/RNF43), have 
been shown to regulate Frizzled and LRP6 homeostasis by catalyzing their ubiquitin-mediated 
degradation (Hao, Xie et al. 2012). The activities of these two E3 ligases are directly inhibited by 
the secreted protein, R-Spondin, upon its binding to the stem cell marker, LGR5 (Hao, Xie et al. 
2012). Thus, nearly all major components of the Wnt pathway are regulated by the ubiquitin 
system, which control their levels and/or activities. 
XIAP 
X-linked inhibitor of apoptosis (XIAP) is an E3 ligase that was originally identified by its 
homology to genes in the genome of baculovirus (Liston, Fong et al. 2001). The baculovirus 
homologs of XIAP were themselves identified in genetic screens for suppressors of cell death 
(Uren, Pakusch et al. 1996). XIAP has been widely studied for its role in regulating apoptosis. 
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Members of the cellular inhibitor of apoptosis (cIAP) protein family contain one to three 
baculovirus IAP repeats (BIRs), which are 70-residue zinc-binding domains. XIAP contains three 
BIRs that can directly bind to caspase-3, -7, and -9 to inhibit their proteolytic activity (Galban and 
Duckett 2010). To date, XIAP is the only IAP family member that binds to the active site of 
caspases to inhibit their activities (Eckelman, Salvesen et al. 2006). Another key feature of IAP is 
the RING finger motif, which confers E3 ligase activity. The RING domains of IAP proteins 
(located at the C-terminal ends of the proteins) are much more similar in sequence to each other 
than to the RINGs of other E3 ligases (Galban and Duckett 2010). Upon viral infection, the RING 
domain has been found to enhance the antiapoptotic activity of IAPs (Suzuki, Nakabayashi et al. 
2001).  
XIAP itself can be degraded through the ubiquitin-proteasome pathway and is capable of 
autoubiquitination in a manner that is dependent on its RING domain (Lotocki, Alonso et al. 2003). 
However, the types and degree of ubiquitination on XIAP itself are not clearly understood, 
although K48 linkage has been proposed as the candidate modification. The association between 
XIAP autoubiquitination and cell death is not clearly defined. For example, it is not known if 
autoubiquitination occurs as a result of cell death or whether autoubiquitination and degradation 
of XIAP occur prior to cell death. Studies into XIAP function have also been complicated by the 
fact that XIAP-deficient mice are healthy and exhibit no obvious defects in apoptosis (Harlin, 
Reffey et al. 2001). It has been proposed that other IAPs, such as cIAP1 and cIAP2, could 
compensate for XIAP function in the XIAP-deficient mice (Olayioye, Kaufmann et al. 2004).  
The mechanism by which XIAP is autoubiquitinated is also incompletely understood. It is 
possible that autoubiquitination involves other factors, whereby binding induces a conformational 
change in XIAP that allows for its autoubiquitination. Affinity purification approaches have 
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identified a number of proteins that bind XIAP, and they are diverse in sequence and structure 
(Vaux and Silke 2003). However, they all contain a tetrapeptide domain known as the IAP-binding 
motif (IBM), which confers the ability to bind XIAP. One of the best characterized IBM-
containing protein is Smac (Diablo). Smac is released from the mitochondria in response to 
apoptotic signals, such as cytochrome c. Smac has also been shown to bind to XIAP and neutralize 
its apoptosis-inhibiting activities (Du, Fang et al. 2000). Other IBM-containing peptides have been 
shown to induce XIAP turnover in a RING-dependent manner. Studies have shown that cIAPs can 
also ubiquitinate XIAP (Galbán, Hwang et al. 2009). Further studies are needed to elucidate the 
regulation of XIAP turnover. 
In addition to autoubiquitination, XIAP can also ubiquitinate other proteins. For example, 
XIAP can ubiquitinate apoptosis-inducing factor (AIF) and promote its degradation (Wilkinson, 
Wilkinson et al. 2007). XIAP has also been shown to ubiquitinate Survivin, in a mechanism 
requiring the XIAP-associated factor-1 (XAF1) (Arora, Cheung et al. 2007). Surprisingly, studies 
have also shown that XIAP can ubiquitinate Smac, whose binding induces the turnover of XIAP 
itself. It is therefore very possible that XIAP and its associated proteins exist in a dynamic 
equilibrium.  
Beyond its role in apoptosis, increasing evidence indicate that XIAP can participate in a 
variety of signaling pathways. For example, there is a growing body of literature showing that 
XIAP regulates NF-kB signaling. A number of studies have shown that XIAP overexpression is 
able to activate NF-kB reporter activity, and that the RING domain is required for such activity 
(Barkett, Xue et al. 1997). A number of substrates in the NF-kB have been proposed to be targets 
of XIAP ubiquitination. TGF-beta Activating Kinase-1 (TAK1), a serine threonine kinase, is a 
major component of the NF-kB signaling and has been shown to form a complex with and be 
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ubiquitinated by XIAP (Hofer-Warbinek, Schmid et al. 2000). Another XIAP substrate is Copper 
Metabolism (Murr1) Domain Containing 1 protein (COMMD1), which plays a role in the 
ubiquitination of chromatin-bound NF-kB proteins to suppress NF-kB signaling. It has been 
hypothesized that XIAP activates NF-kB dependent transcription by negatively regulating the 
activity of COMMD1 (Burstein, Hoberg et al. 2005).  
The identification of XIAP as a regulator of Wnt signaling 
Previous models of Wnt signaling proposed that, upon Wnt signaling, beta-catenin 
displaces the co-repressor, Gro/TLE, from TCF. In this model, elevated levels of nuclear beta-
catenin is sufficient to displace Gro/TLE by mass action (Daniels and Weis 2005). Other studies, 
however, have shown that the increase in beta-catenin levels upon Wnt pathway activation can be 
as small as two-fold when compared to the basal state (Goentoro and Kirschner 2009). Thus, it is 
difficult to envision that beta-catenin can displace Gro/TLE from TCF via a simple competitive 
mechanism, and there is likely to be a facilitated mechanism by which Gro/TLE is removed from 
TCF upon Wnt signaling. 
Taking advantage of the conserved nature of the Wnt pathway, Dr. Alison Hanson in our 
lab conducted an RNAi screen in Drosophila S2 cells to identify new E3 ligases that could regulate 
Wnt signaling. One gene identified as a potential positive regulator of Wnt signaling was DIAP1 
(Drosophila inhibitor of apoptosis 1). XIAP is the mammalian homolog of DIAP1, and our lab 
proceeded to characterize the role of XIAP in Wnt signaling. In cultured human cells, knocking 
down XIAP with siRNA inhibited ligand-induced Wnt activation. XIAP is required for Wnt 
signaling in vivo, and knocking XIAP using morpholino oligonucleotides resulted in axis 
patterning defects consistent with Wnt inhibition. XIAP functions downstream of the beta-catenin 
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destruction complex, as evidenced by the observation that knocking down XIAP inhibits Wnt 
activation by the addition of GSK3 inhibitors. A candidate approach was then undertaken to 
determine the Wnt component that interacted with XIAP. Gro/TLE was identified as a potential 
candidate (Hanson, Wallace et al. 2012).  
Subsequent studies showed that XIAP also binds TCF upon Wnt activation. Ubiquitination 
assays demonstrated that XIAP ubiquitinates Gro/TLE in vitro using purified components and in 
cultured mammalian cells, and ubiquitinated Gro/TLE exhibited decreased binding affinity to 
TCF4. These important studies led to a new model for nuclear activation of the Wnt pathway 
whereby, upon Wnt pathway activation, XIAP is recruited onto TCF.  Bound XIAP ubiquitinates 
Gro/TLE to decrease its affinity for TCF, thereby facilitating the binding of beta-catenin to TCF 
(Hanson, Wallace et al. 2012).  
A major unanswered question in the proposed model is how XIAP is recruited to the 
Gro/TLE –TCF complex upon Wnt signaling.  A hint of how this process may be controlled came 
from Dr. Hanson’s studies that a Wnt pathway activator, lithium (inhibits GSK3), is capable of 
promoting the association of XIAP with TCF (Hanson, Wallace et al. 2012). Previous studies have 
shown that GSK3 and XIAP interact through the latter’s RING domain (Sun, Meares et al. 2009). 
Thus, GSK3 may directly regulate the recruitment of XIAP onto TCF upon Wnt pathway 
activation. 
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Figure 1.1. The current model of Wnt signaling. Left panel: In the absence of Wnt, cytoplasmic 
β-catenin forms a complex with APC, Axin, GSK3, and CK1α. β-Catenin is phosphorylated by 
CK1α and subsequently phosphorylated by GSK3. The phosphorylated form of β-catenin is 
recognized by the E3 ubiquitin ligase SCFβ-TRCP, which targets β-catenin for proteasomal 
degradation. In the absence of nuclear β-catenin, Wnt target genes are repressed. Right panel: In 
the presence of Wnt ligand, a receptor complex forms between Fz, LRP5/6, and Wnt. The 
recruitment of Dsh by Fz leads to LRP5/6 phosphorylation by CK1α and GSK3 followed by 
recruitment of Axin to LRP5/6. The latter disrupts Axin-mediated phosphorylation/degradation of 
β-catenin, leading to accumulation of β-catenin in the cytoplasm and its translocation to the 
nucleus, where it acts as a transcriptional co-activator with TCF to activate Wnt-responsive target 
genes. Figure from (Saito-Diaz, 2013). 
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Chapter II: Materials and Methods 
Expression and purification of XIAP 
BL21 bacterial cells were transformed with MBP-XIAP or MBP-XIAP phosphomutant 
plasmids and grown in a 37°C shaking incubator. IPTG (300 uM) was then added when the OD of 
the culture reached 0.8. Flasks were then moved to an 18°C shaking incubator for an overnight 
induction. Cultures were then spun down, pellets was collected, and cells lysed by sonication in 
Tris-NaCl-phenylmethylsulfonyl fluoride (TNP) buffer (50mM Tris-HCl, 150mM Nacl, 2mM 
EDTA, 1mM phenylmethylsulfonyl fluoride (PMSF), 0.1% Triton X-100). Lysates were 
centrifuged at 12,000g at 4°C for 10 minutes and supernatant collected. Supernatants were then 
incubated with amylose beads on a shaking platform for two hours at 4°C. The beads were washed 
with ten column volumes of TNP buffer three times and then MBP-bound protein was eluted with 
TNP buffer containing 1% maltose. Eluted proteins were further purified on a Mono Q anion-
exchange column using the AKTA FPLC apparatus (GE Healthcare). Fractions containing the 
MBP fusion proteins were collected and concentrated using Amicon Ultra Centrifugal Filter Units 
(Millipore) by spinning at 3,000 rpm for twenty minutes, to a final concentration of approximately 
1ug/ul in TNP buffer. Samples were then aliquoted and stored at -80°C until use. 
XIAP in vitro phosphorylation assay 
For radioactive kinase assays, 2ug of XIAP was added, along with 250 units of GSK3 (New 
England Biolabs), 5 mM of cold ATP, 5 uCi of [32P]ATP in 1X kinase reaction buffer (50mM 
Tris-HCl, 10mM MgCl2, 5mM dithiothreitol (DTT), pH 7.5). Reactions were incubated at 30 °C 
for one hour, and reactions processed for SDS-PAGE followed by autoradiography.  
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Mass spectrometry analysis 
A kinase reaction was performed as described for the in vitro phosphorylation reaction 
except no radioactive ATP was added. The reactions were then subjected to SDS-PAGE, and the 
gel stained with coomassie. The band corresponding to XIAP was then excised and subjected to 
liquid chromatography-mass spectrometry (LC-MS) to analyze for XIAP peptides enriched for 
phosphorylation using methods as previously described (Chaturvedi, Asim et al. 2014). 
Mutagenesis 
Forward and reverse primers containing the desired mutation were generated. Briefly, 
polymerase chain reaction (PCR) was performed to generate plasmids containing the mutation 
using the KOD polymerase in a 50ul reaction as previously described (Laible and Boonrod 2009). 
PCR products were digested with Dpn1 to destroy the template plasmid. Dpn1-treated reactions 
were then used to transform DH5 cells. Colonies were grown, plasmids isolated, and plasmids 
sequenced for the presence of the appropriate mutation. 
Immunofluorescence 
Human embryonic kidney 293 cells (HEK293) were grown on coverslips coated with fibronectin, 
fixed in 3.7% formaldehyde, and permeablized. Samples were then incubated with primary 
antibody followed by secondary antibodies conjugated to Cy3 or Alexa 488, and mounted in 
ProLong Gold with DAPI (Invitrogen). Cells were visualized using a Cascade 512B camera 
mounted on a Nikon Eclipse TE2000-E confocal microscope. 
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In vitro ubiquitination assay 
In vitro ubiquitination assays were carried out in 20 ul reactions using the Ubiquitin 
Thioester/Conjugation Initiation Kit (Boston Biochem). Briefly, E1 ubiquitin-activating enzyme 
(1 ug), E2 UbcH5a (1ug), ubiquitin (1ug) and myc-TLE3 (2ug, generated from an in vitro 
transcription-translation reaction) (Promega) were assembled, and samples incubated on a TOMY 
shaker in a 30°C incubator for 30 minutes. Reactions were terminated with the addition of sample 
buffer, and the ubiquitinated products subjected to SDS-PAGE followed by immunoblotting for 
myc (Muratani and Tansey 2003). 
In vivo ubiquitination assay 
HEK293 cells were transfected with HA-TLE3, myc-XIAP, and His-Ubiquitin. Cells were treated 
with MG132 at 10uM for 4 hours prior to lysis. Lysates were sonicated at maximum for three 
pulses, one second each, and centrifuged at 12,000g for 10 minutes at 4°C. Supernatants were 
incubated with Ni-NTA agarose beads at room temperature for three hours. His-tagged proteins 
were eluted and processed for SDS-PAGE followed by immunoblotting for HA (Muratani and 
Tansey 2003). 
TLE3-XIAP binding assay 
HEK293 cells were transfected with HA-TLE3 and myc-XIAP. Cells were treated with MG132 at 
10uM for 4 hours prior to lyses in non-denaturing lysis buffer (NDLB; 100mM Tris-HCl pH7.4, 
500mN NaCl, 5mM EDTA, 1% (w/v) Triton X-100, and 1mM PMSF) plus ubiquitin aldehyde 
(250 ng/ul). Lysates were collected and centrifuged at 12,000g for ten minutes at 4°C.  Anti-myc 
agarose beads were then added to the supernatant and samples incubated overnight at 4°C.  Beads 
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were then washed three times with ten bead volumes of NDLB, bound proteins eluted with sampler 
buffer, and eluted proteins processed for SDS-PAGE and immunoblotting. 
TOPFlash reporter assay 
HEK293 STF (Super TOPFlash) cells containing stably transfected Wnt reporter were incubated 
with Wnt3a-conditioned or control media 24 hours post transfection. After 48 hours, cells were 
lysed with 1X Passive Lysis Buffer (Promega) and luciferase activity determine with Steady Glo 
following the manufacturer instruction (Promega). CellTiter-Glo (Promega) was used to normalize 
luciferase activities. Statistical analysis was performed using the Student's t test. A value of p < 
0.05 was considered statistically significant. 
Axis duplication assay 
Xenopus embryos were in vitro fertilized, de-jellied, cultured, and injected with mRNA as 
previously described (Peng 1991). Embryos were assessed for complete or partial duplication and 
statistical analysis was performed using Fisher’s exact test. A value of p < 0.05 was considered 
statistically significant. All animal studies were approved by the Institutional Animal Care and 
Use Committee (IACUC) at Vanderbilt University Medical Center and were in accordance with 
their policies. 
Immunoblotting 
For immunoblotting, cells were typically lysed in non-denaturing lysis buffer (NDLB). Lysates 
were centrifuged at 12,000g for ten minutes at 4°C, and supernatants collected for SDS-PAGE. 
After transfer, PVDF membranes were blocked in TBS with 5% milk and incubated with primary 
21 
 
antibodies overnight at 4°C. Membranes were then washed with TBS three times and incubated 
with secondary antibodies at room temperature for 2 hours. 
 
Plasmids 
pCS2-myc-XIAP, pCS2-myc-XIAPRING, pCS2-myc-TLE3, pCS2-HA-TLE3, pMAL-XIAP, 
pMAL-XIAPRING, pGEX-TEV-GST were provided by the Ethan Lee lab. pMT107 (His-Ub) 
was a gift from Bill Tansey at Vanderbilt University. pCS2-myc-XIAP T180A, pCS2-myc XIAP 
S239A, pMAL-myc-XIAP T180A, and pMAL-myc XIAP S239A were generated using PCR-
based mutagenesis techniques, using the following primers: 
T180A: Forward-5’-ggccagactatgctcacctagccccaagagag-3’, Reverse-
5’ctctcttggggctaggtgagcatagtctggcc-3’. 
S239A: Forward-5’-ttgggccggaatcttaatattcgagctgaatctgatgctgtg-3’, Reverse-
5’cacagcatcagattcagctcgaatattaagattccggcccaa-3’ 
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Chapter III: Results 
XIAP is a GSK3 substrate in vitro 
One study has shown that XIAP binds GSK3 (Sun, Meares et al. 2009). It was unknown, 
however, whether XIAP was phosphorylated by GSK3. In order to determine whether XIAP is a 
kinase substrate of GSK3, we performed a radioactive in vitro kinase reaction using purified GSK3 
and MBP-tagged XIAP. Because MBP is also a substrate for XIAP, the MBP tag of the MBP-
XIAP fusion was cleaved using TEV-protease.  As shown in Figure 1, XIAP is phosphorylated by 
GSK3. In order to determine potential GSK3 sites on XIAP, we used the Eukaryotic Linear Motif 
(ELM) Resource Program (a protein motif and peptide modification analysis tool), and found that 
XIAP was predicted to contain eight putative GSK3 phosphorylation sites distributed evenly 
across the protein (Figure 2). In order to experimentally identify sites on XIAP that are 
phosphorylated by GSK3, we performed an in vitro kinase reaction with purified MBP-XIAP and 
GSK3, and processed the reaction for liquid chromatography-mass spectrometry (LC-MS). From 
the LC-MS results, we identified two major sites that were subsequently validated: threonine 180 
(T180), which is located within the BIR1 domain, and serine 239 (S239), which is located in the 
region between the BIR1 and BIR2 (Figure 3).  
 
XIAP phosphomutants exhibit altered Wnt activity in cultured human cells 
In order to determine whether the T180 and S239 sites of XIAP play a role in XIAP 
function in the Wnt pathway, we performed site-directed mutagenesis (to mutate these sites to 
alanines) to generate the XIAP mutants, XIAP T180A and S239A.  We tested their effects in a 
Wnt reporter cell line, HEK293 STF. As previously shown, overexpression of XIAP has no 
observable effect on Wnt signaling as detected by the Wnt reporter assay (Figure 4). Similarly, we 
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did not detect any observable effect on Wnt signaling when the XIAP T180A and S239A mutants 
were overexpressed. We previously showed that knocking down XIAP blocked Wnt signaling, 
demonstrating its requirement for Wnt signal transduction. Our incapacity to detect activation of 
the Wnt pathway in cultured mammalian cells may be due to the fact that XIAP is not normally a 
limiting Wnt component in the absence of Wnt pathway activation. It is possible, however, that 
XIAP may become limiting when the Wnt pathway is activated. We tested this possibility, and 
showed that overexpression of XIAP potentiates the effect of Wnt3a (Fig. 4). The lack of increased 
beta-catenin levels above that of Wnt3a is consistent with the function of XIAP in the nucleus, 
downstream of the beta-catenin destruction complex. In contrast, we did not observe any 
enhancement of Wnt3a-mediated reporter activity when the XIAP T180A and S239A mutants 
were overexpressed.  In fact, we observed inhibition of Wnt activity (compared to vector control) 
when the XIAP T180A and S239A mutants were overexpressed. Thus, phosphorylation of T180 
and S239 on XIAP appear to play a role in the capacity of XIAP to enhance Wnt signaling, and 
XIAP T180A and S239A phosphomutants may be working in a dominant-negative fashion to 
inhibit maximal Wnt pathway activation. 
 
XIAP phosphomutants do not have altered cellular localization 
XIAP is localized predominantly to the cytoplasm, albeit there is a small XIAP pool that 
resides in the nucleus. Because phosphorylation has been shown to regulate the subcellular 
localization of proteins, we performed immunolocalization of the XIAP phosphomutants to 
determine if they were altered when compared to the wild-type protein. We transfected wild-type 
myc-XIAP, myc-XIAP T180A, and myc-XIAP S239A into HEK293 cells and performed 
immunostaining with an anti-myc antibody (Figure 5).  We found there was no difference between 
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the cellular localization of wild-type XIAP and the XIAP phosphomutants, in that the mutants 
remained in the cytoplasm 
 
XIAP phosphomutants affect axis duplication in Xenopus embryos 
Next we aimed to assess the developmental functions of XIAP phosphomutants in vivo.  
Induction of secondary axis formation in Xenopus embryos is a powerful in vivo readout for Wnt 
signaling. We previously demonstrated that morpholino knockdown of XIAP resulted in 
ventralized embryos, and that injection of mRNA encoding XIAP induced secondary axis 
formation in Xenopus embryos. These studies demonstrated that XIAP plays a critical role in 
dorsal-anterior patterning in Xenopus embryos, a process regulated by Wnt signaling.  
To test the effect of the XIAP mutants on axis formation, we injected Xenopus embryos 
with mRNAs encoding the XIAP T180A and S239A phosphomutants. We found that the XIAP 
phosphomutants were able to induce secondary axis formation to a similar extent as wild-type 
XIAP (Figure 6A). We observed potentiation when wild-type XIAP mRNA was co-injected with 
Xwnt8 mRNA into Xenopus embryos. We next tested if the XIAP phosphomutants were able to 
similarly potentiate co-injected Xwnt8. We found that the XIAP phosphomutants demonstrated 
much less activity than wild-type XIAP (Figure 6A). In the case of the XIAP T180A 
phosphomutant, co-injection of Xwnt8 resulted in a lower activity when compared to injection of 
Xwnt8 alone. These studies indicate that in vivo, in Xenopus embryos, similar to what was 
observed in cultured human cells, the XIAP T180A and S239A phosphomutants have impaired 
capacities to potentiate Wnt signaling.  In the case of XIAP T180A, the phosphomutant also appear 
act in a dominant negative fashion.  
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The XIAP phosphomutants retain their capacity to ubiquitinate Gro/TLE in vitro but not in 
cultured human cells 
We have previously shown that XIAP ubiquitinate TLE3 in vitro and in cultured 
mammalian cells. To directly test whether the decreased capacity of XIAP phosphomutants to 
potentiate Wnt signaling is due to their decreased capacity to ubiquitinate Gro/TLE, we expressed 
and purified recombinant wildtype XIAP and the XIAP T180A and S239A phosphomutants from 
bacteria and tested their capacity to ubiquitinate TLE3 in an in vitro ubiquitination assays (Fig. 7). 
We found that in vitro, the XIAP phosphomutants were able to ubiquitinate Gro/TLE to a similar 
degree as wild-type (Figure 8). Next we tested if there was a difference in the ubiquitination 
activities between wild-type XIAP and the XIAP phosphomutants in cultured human cells. HEK93 
cells were transfected with HA-TLE3, His-ubiquitin, and either wild-type XIAP or XIAP 
phosphomutants. As negative control, the XIAPRING mutant, which lacks the RING domain 
necessary for its E3 ligase activity, was also transfected. His-ubiquitinated proteins were isolated 
under denaturing conditions by nickel affinity purification, and HA-TLE3 was detected by 
immunoblotting (Fig. 9). We found that, as predicted, wild-type XIAP promoted the ubiquitination 
of HA-TLE3, as evidenced by the higher molecular weight species of TLE3. Neither of the 
phosphomutants, however, promoted the ubiquitination of TLE3 and they were indistinguishable 
from the XIAPRING control. Thus, in contrast to the purified in vitro situation, the XIAP T180A 
and S239A phosphomutants have a decreased capacity to promote the ubiquitination of TLE3 in 
cultured cells. These differences in the activities of the XIAP mutants between the reconstituted 
purified and the cell-based ubiquitination assays may be due to the fact that in cells, in contrast to 
the in vitro reconstituted system, wild-type XIAP is phosphorylated. These studies highlight the 
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importance of XIAP phosphorylation in regulating its capacity to ubiquitinate Gro/TLE, and that 
the XIAP T180A and S239A phosphomutants do not have reduced intrinsic catalytic activity. 
 
XIAP phosphomutants exhibit decreased affinity for TLE3 in mammalian cells 
The decreased capacity of XIAP to ubiquitinate TLE3 in cultured cells could be due to their 
decreased catalytic activity or decreased affinity for TLE3. In order to test the latter possibility, 
we performed co-immunoprecipitation studies between the XIAP phosphomutants and TLE3.  Cell 
were transfected with HA-TLE3 and either wild-type myc-XIAP or myc-XIAP phosphomutants. 
XIAP and XIAP phosphomutants were pulled-down with anti-myc agarose beads and 
immunoblotted for HA-TLE3 (Fig. 10). We found that, in contrast to TLE3 and wild-type XIAP, 
the interaction between TLE3 and XIAP was significantly reduced with the XIAP T180A and 
S239A mutants. Furthermore, the addition of Wnt3 did not significantly enhance the interaction 
between TLE3 and the XIAP mutants (Fig.10).  These results indicate that the decreased capacity 
of the XIAP phosphomutants to ubiquitinate TLE3 is due, in part, to their decreased binding to 
TLE3. 
 
 
 
 
 
27 
 
 
Figure 2.1. XIAP is a substrate of GSK3 in vitro. (A) Coomassie stain of purified XIAP-MBP. 
XIAP-MBP was expressed and purified from bacteria. (B) Autoradiography of phosphorylated 
XIAP. Kinase reaction using TEV-protease cleaved XIAP-MBP was incubated at 37°C for 1 hour. 
Reactions were analyzed by SDS/PAGE followed by autoradiography. 
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Figure 2.2. Putative GSK3 phosphorylation sites on XIAP. Sites were identified using the 
Eukaryotic Linear Motif (ELM) Resource Program.   
 
 
Figure 2.3. LC-MS analysis identifies T180 and S239 on XIAP as sites of phosphorylation by 
GSK3 in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
Figure 2.4. Overexpression of XIAP T180A and S239A phosphomutants has impaired 
capacities to potentiate Wnt signaling in cultured human cells.  (A) Wnt signaling in HEK293 
STF cells is potentiated upon overexpression of wild-type XIAP but not by overexpression of 
XIAP T180A and S239A phosphomutants. HEK293 cells were transfected with XIAP constructs 
for 24 hours and followed by treatment with vehicle or Wnt3a media. Reporter activity was 
assessed 72 hours post-transfection. Graph shows mean +/- SD of TOPflash normalized to cell 
titer.***p value <0.0001. (B) Immunoblotting shows beta-catenin stabilization by Wnt3a 
treatment but not by overexpressing XIAP constructs. 
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Fig 2.5. XIAP phosphomutants show similar localization to wild-type XIAP. HEK 293 STEF 
cells were transfected with wild type myc-XIAP, myc-XIAP T180A, and myc-XIAP T239A. Cells 
were fixed and stained for myc. DNA is stained with DAPI. 
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Figure 2.6. XIAP phosphomutants have decreased capacity to induce secondary axis 
formation in combination with Xwnt8 in Xenopus embryos. Xenopus embryos were injected 
in one ventral blastomere at the 4-cell stage with mRNAs (2 ng each) encoding XIAP, XIAP 
T180A, or XIAP S239A with or without 1 ng of Xwnt8. Embryos were allowed to develop for 48 
hours and prior to analysis for axis duplication. (A) XIAP phosphomutants induced axis 
duplication to a similar extent as wild-type XIAP. Co-injection of XIAP mRNA significantly 
potentiated Xwnt8-induced axis duplication in contrast to the XIAP phosphomutants. ***p value 
< 0.001 versus wild-type + Xwnt8. (B-D) Representative images of the axis duplication assay. 
Representative pictures of embryos showing (B) uninjected control, (C) Xwnt8 injected, and (D) 
wild-type XIAP injected embryos. 
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Figure 2.7. Purified MBP fusion of XIAP. XIAP T180A, and XIAP T239A. MBP fusions of 
wild-type and XIAP phosphomutants were expressed and purified from bacteria by amylose 
affinity resin followed by Mono Q anion exchange chromatography. Proteins (1 ug each) were run 
on SDS-PAGE followed staining with Coomassie Brilliant Blue. 
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Figure 2.8. XIAP T180A and T239A ubiquitinate TLE3 in vitro to a similar extent as wild-
type XIAP. In vitro translated HA-TLE3 was incubated with recombinant XIAP constructs and 
other ubiquitination components as indicated and visualized by immunoblotting with anti-HA 
antibody. 
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Fig 2.9. XIAP T180A and S239A have reduced capacity to ubiquitinate TLE3 in cultured 
human cells. HEK293 cells were transfected as indicated, lysed under denaturing conditions, and 
His-Ub modified proteins isolated by nickel affinity purification. XIAP and TLE were detected by 
immunoblotting with anti-myc and anti-HA antibodies, respectively. 
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Figure 2.10. XIAP phosphomutants have a decreased affinity for TLE3. HEK293 cells were 
transfected as indicated with myc-XIAP and HA-TLE3 in the presence or absence of Wnt3a. Cells 
were lysed and XIAP immunoprecipitated with anti-myc antibody. Co-immunoprecipitated TLE3 
was detected by anti-HA antibody.
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Chapter IV: Discussion and future directions 
Discussion 
How the Wnt transcriptional complex is converted from a repressor complex into an 
activator complex is not well understood. Previous studies have shown that nuclear beta-catenin 
levels increase only modestly (2-6 fold) upon Wnt pathway activation (Goentoro and Kirschner 
2009). Given that the affinity between Gro/TLE and TCF/Lef is in the low-mid nanomolar range, 
such an increase in beta-catenin levels is unlikely to be sufficient for beta-catenin to displace 
Gro/TLE via direct competition. Previously, we showed that upon Wnt activation, XIAP is 
recruited onto Wnt gene promoters to ubiquitinate Gro/TLE bound TCF/Lef, decreasing its affinity 
for TCF/Lef (Hanson, Wallace et al. 2012). Because XIAP can ubiquitinate Gro/TLE whether or 
not Gro/TLE is bound to TCF/Lef on Wnt gene promoters, our model proposes that XIAP also 
prevents free nuclear Gro/TLE from binding TCF/Lef.  Regardless, we propose this Wnt signaling 
circuitry provides a mechanism to dampen transcriptional noise without a corresponding loss in 
sensitivity. It is not clear how Gro/TLE ubiquitination is regulated, and we speculate that there 
exists a deubiquitinase that may facilitate the binding of Gro/TLE to TCF/Lef in the Wnt 
unstimulated state. Such cycles of mono-ubiquitination and de-ubiquitination have been observed 
with other transcriptional activators including Smad4, p53, and FoxO (van der Horst, de Vries-
Smits et al. , Dupont, Mamidi et al.).   
A major question that arises from our proposed model is how XIAP is recruited to the 
TCF/Lef transcriptional complexes in a Wnt dependent manner. Our preliminary studies indicate 
that inhibiting GSK3 with lithium was sufficient to promote XIAP recruitment to TCF. We 
therefore hypothesized that phosphorylation may play a role in regulating XIAP activity. Our 
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current data suggests a model in which XIAP phosphorylation is crucial for the interaction between 
XIAP and Gro/TLE to allow full Wnt activation (Figure 1).  
We now know that cellular regulatory mechanisms provide specific and robust responses 
to external stimuli, and posttranslational modifications often provide a dynamic way to regulate 
protein activity and protein-protein interactions (Nishi, Hashimoto et al. 2011). Such dynamic 
regulation can be achieved through the reversible and the fast kinetics of post-translational 
modifications (Johnson 2009). It has been shown that a majority of proteins in a cell contains at 
least a few phosphosites, and that regulation through phosphorylation is very common. 
Phosphorylation has been shown to induce conformational changes through allosteric 
mechanisms, and has been demonstrated to modulate the association and dissociation of protein 
assemblies in numerous signaling pathways (Gsponer, Futschik et al. 2008).  
Because XIAP is involved in cellular pathways other than Wnt signaling, it is possible that 
phosphorylation at different sites on XIAP confers specificity for its interaction with different 
binding partners. In the present study, we found that phosphorylation at T180 and S239 of XIAP 
increases its affinity of XIAP for Gro/TLE and is required for maximal Wnt activity in cultured 
human cells. In Xenopus embryos, we showed that wild-type and XIAP phosphomutants were able 
to induce axis duplication at a similarly low rate (~10-15%). When co-injected with Xwnt8, 
however, the differences between wild-type XIAP and the XIAP phosphomutants became evident: 
wild-type XIAP potentiated the activity of Xwnt8 whereas the XIAP phosphomutants had no effect 
(S239A) or inhibited (T180A) the activity of Xwnt8. These in vivo results parallel our findings in 
cultured cells and indicate that the XIAP phosphomutants are acting in a manner reminiscent of 
partial agonists in drug-receptor interaction (Hoyer and Boddeke 1993). 
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It remains to be determined why phosphorylation of XIAP on T180 and S239 is required 
for full Wnt activity. Previous studies have shown that beta-catenin interacts with adapter proteins 
such as Pygo within the co-activator complex to promote maximal transcription (Townsley, Cliffe 
et al. 2004). In the nucleus, the tumor suppressor APC has been proposed to aid in the switch 
between the transcriptional activation and repression by binding beta-catenin and facilitating its 
dissociation from the promoter (Sierra 2006). It is possible that XIAP interacts with these adaptor 
proteins via these phosphosites. Thus, XIAP phosphomutants could have altered interaction with 
these nuclear adaptor proteins. Finally, there is strong evidence that a cyclic pattern of alternating 
co-activator and co-repressor complex recruitment to Wnt gene promoters is required for maximal 
Wnt transcriptional activation (Sierra 2006). This cycling may represent a necessary resetting of 
the transcriptional complex after each round of transcription. Studies from our lab have shown that 
XIAP binding and dissociation from Wnt gene promoters parallel this cyclic pattern. It is possible 
that phosphorylation at S239 and T180 is important for cycling on and off the promoter of Wnt 
target genes. Thus, the XIAP phosphomutants are able to undergo a single round of Wnt activation 
(low activation), but are impaired in cycling through multiple rounds of activation (high 
activation). This possibility could be tested by performing kinetic ChIP assays to monitor the 
cycling of XIAP phosphomutants on and off the promoter. 
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Future directions 
My studies have provided new and important insight into the function of XIAP in the Wnt 
pathway and its regulation by phosphorylation. I have shown that phosphorylation of XIAP is 
required for its full function in the Wnt pathway. Major questions, however, remain regarding the 
nature and mechanism of XIAP phosphorylation. For example, in order to obtain maximal XIAP 
activity in the Wnt pathway, does the phosphorylation at positions T180 and S239 have to be 
reversible? We can test this possibility by generating XIAP phosphomimetics mutants at positions 
T180 and S239, and test if these mutants function similarly to wild-type XIAP or to the alanine 
mutants.   
The XIAP phosphomutants appear to retain full catalytic activity as demonstrated in our in 
vitro ubiquitination assays. In our cell-based assays, however, the mutants have impaired capacity 
to ubiquitinate TLE3, consistent with its decreased affinity for the substrate. It would be interesting 
to know whether the XIAP phosphomutants similarly have decreased activity towards a known 
XIAP substrate in another pathway (e.g. Smac). To test this possibility we could perform cell-
based ubiquitination assays using Smac. If we do not detect any difference in the capacity of the 
XIAP phosphomutants to ubiquitinate Smac, in contrast to TLE3, it would suggest that these 
phosphorylation sites are involved in regulating XIAP substrate specificity. 
To date, we have not been able to demonstrate that the T180 and S239 sites are 
phosphorylated in vivo by mass spectrometry. This may be due to the fact that the percentage of 
the total XIAP pool that participates in Wnt signaling is relatively small.  A multitude of factors, 
including occupancy, charge, and hydrophobicity, can affect the chromatographic properties and 
ionization efficiencies and thus the ease of detection of phosphorylated peptides in cells 
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(Dephoure, Gould et al. 2013). Alternatively, the phosphorylation sites on XIAP are labile and 
may turn over rapidly, negating proper detection via mass spectrometry. 
One way to overcome these hurdles is to develop antibodies that recognize the 
phosphorylated T180 and S239 sites. These antibodies will be helpful in determining 1) whether 
phosphorylation of XIAP is regulated by Wnt signaling, 2) whether XIAP is phosphorylated in the 
cytoplasm or nucleus, 3) whether the phosphorylated/dephosphorylated state of XIAP parallels its 
cycling on and off Wnt gene promoters, and 4) whether phosphorylation of XIAP at T180 and 
S239 is mediated by GSK3 in vivo.  
Proteins often undergo cycles of ubiquitination and deubiquitination to modulate their 
activities. Removal of ubiquitin may be required for cycling Gro/TLE back onto TCF to 
reconstitute the co-repressor complex during Wnt signaling and upon termination of the Wnt 
signal. The deubiquitinase (DUB) that counteracts the activity of XIAP on Gro/TLE is not known. 
Unlike E3 ligases, which number in the hundreds, there are only about eighty DUBs. Therefore, 
an RNAi screen in cultured mammalian cells could be performed to identify DUBs that, when 
knocked down, would increase the extent of ubiquitinated Gro/TLE by XIAP using the His-
Ubiquitin assay. 
Previous studies from our lab have shown that the N-terminal Q domain of Gro/TLE 
contains the site of interaction with XIAP.  However, the region of XIAP that binds Gro/TLE has 
not been mapped. It is possible that the region of XIAP that binds Gro/TLE lies within a region 
that spans T180 and S239. It is equally possible that phosphorylation at these sites induces 
conformation changes in an allosteric fashion to affect binding at distant domains. Regardless, 
given that we can readily express and purify XIAP and that XIAP can be readily 
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coimmunoprecipitated with TLE3, a simple binding assay could be developed to determine the 
region of XIAP that interacts with Gro/TLE.  
 XIAP is overexpressed in a majority of human cancers, and drugs that target XIAP are 
currently in clinical trials. Our studies demonstrate that XIAP potentiates Wnt signaling. These 
results suggest that XIAP misregulation may further contribute to enhance Wnt signaling in 
cancers with inappropriate Wnt pathway activation. Our previous studies showed that XIAP 
regulate the Wnt pathway downstream of 90% of all Wnt mutations in cancer (e.g. APC and beta-
catenin). Thus, inhibiting the activity of XIAP may be one way to target cancers due to mutations 
in the Wnt pathway. Results from our current studies may be helpful in devising more specific, 
targeted approaches for inhibiting the Wnt activity of XIAP. Most of the drugs targeting XIAP 
have focused on its BIR domains. Our data suggests that the T180 and S239 phosphosites on XIAP 
are required for full Wnt activation. Small molecule inhibitors that target these regions may be 
selective for inhibiting the function of XIAP in Wnt signaling, but leaving intact other 
physiological functions of XIAP. 
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Figure 3.1. GSK3 phosphorylation is required for the interaction between XIAP and 
Gro/TLE. GSK3 phosphorylates XIAP at T180 and S239 to facilitate its binding to Gro/TLE. 
XIAP can then ubiquitinate and remove Gro/TLE for subsquent binding of beta-catenin to the 
promoter. 
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Appendix A: Screen for small molecule modulators of major embryonic pathways 
This chapter was published as Screening for small molecule inhibitors of embryonic pathways: 
sometimes you gotta crack a few eggs. Hang BI, Thorne CA, Robbins DJ, Huppert SS, Lee LA, 
Lee E. Bioorg Med Chem. (2012)  
 
Introduction 
In this review, we will discuss the unique biological properties of the Xenopus egg extract 
system and the advantages it offers for screening small molecular modulators of complex 
biological pathways. We will discuss molecular pathways that have been reconstituted using 
Xenopus egg extracts and small molecule screens that have been performed using these assays. 
Finally, we will describe our recent studies using Xenopus egg extracts to identify small molecule 
modulators of the Wnt pathway and how this approach could be similarly adapted to other 
embryonic signaling pathways such as Hedgehog and Notch. 
Over the past decade, there has been a great expansion in drug discovery efforts within 
academia as evidenced by the emergence of a new discipline known as Chemical Biology 
(Mitchison 1994). With the advent of high throughput approaches and the development of faster 
and cheaper technologies, industry and academia have tremendous resources and opportunities to 
identify novel drugs at an accelerated pace. Traditionally, pharmacological agents have been 
identified through enzymatic assays using purified components (Lindsay 2003, Overington, Al-
Lazikani et al. 2006). Such “targeted screening” approaches, which have been the focus of drug 
discovery over the past decade or so, offer a number of advantages. First, targeted biochemical 
screens represent the most direct way to identify drugs based on our current understanding of a 
molecular target or event. Second, enzymatic assays using purified components can often be 
readily adapted for high throughput screening (HTS); combined with well-established 
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colorimetric, fluorescent, and luminescent readouts, experimental set-up is often relatively 
straightforward. Third, with purified components, drug target identification is not a limitation. 
Fourth, the recent advent of increasingly sophisticated technologies has allowed investigators to 
acquire very precise kinetic data. Such information can facilitate the grouping of drugs into 
subclasses based on mechanism even at initial stages of screening and can reveal subtle drug 
effects as well.  
Targeted screening, however, has some major limitations. The most obvious is that the 
investigator is restricted to the originally hypothesized target; thus, there is no potential for 
uncovering novel targets. Furthermore, it is exceedingly difficult to predict which compounds will 
work in vivo or even whether the targeted molecule will be an effective therapeutic target in the 
first place. An alternative approach to targeted drug screening is to screen for a specific phenotype 
(Mitchison 1994, Yeh and Crews 2003). Phenotypic screens can be performed in systems ranging 
from cultured cells to whole organisms. In fact, in recent years, a majority of compounds receiving 
FDA approval were discovered through phenotypic screens (Swinney and Anthony). These require 
no a priori knowledge of the direct target of compounds, only knowledge of the desired phenotype. 
Representative phenotypic screens include those based on C. elegans morphology, gastrulation in 
zebrafish, and mitosis in cultured mammalian cells (Peterson and Fishman 2004, Kwok, Ricker et 
al. 2006, DeMoe, Santaguida et al. 2009). Screening in such complex systems pre-selects for 
compounds that are cell/organism permeable, reach their target, and induce a desired effect in vivo; 
as such, hits are proven to be active in vivo from the start. The identification of novel drug targets 
can lend to important insights into the biological process in question. 
As with targeted screening, there are also major drawbacks to phenotypic screening. Living 
systems are much more difficult to manipulate in HTS format and require significantly more 
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manual set-up. Phenotypes can often require time-consuming manual inspection or sophisticated 
algorithms for image analysis. Drug incubation times are longer (i.e. on the order of hours to days) 
such that screens require significantly more time to perform. The longer time course also increases 
the likelihood that the desired phenotypes may occur via non-direct mechanisms. Finding the 
optimal dose of drug to screen is another challenge: too low of a drug concentration can give false 
negative results, whereas too high of a drug concentration can produce toxicity with a valid drug 
candidate. Perhaps the major limitation of phenotypic screens, however, is the difficulty of drug 
target identification, which can represent a formidable challenge. 
The Xenopus egg extract system 
Cell extract-based screens, such as those performed using Xenopus egg extract, represents 
an ideal bridge between targeted and phenotypic screens. Xenopus egg extracts offers a powerful 
cell-free system to study complex biological pathways. A multitude of cellular events can be 
recapitulated in extracts (discussed below). In contrast to targeted screens, enzymes can be 
monitored in their native milieu that allows for appropriate post-translational modifications and 
regulation. Thus, using Xenopus egg extract, drugs that target enzymes directly as well as those 
that target unknown cofactors can be identified. In contrast to phenotypic-based screens, enzymes 
can be studied in a homogenous biochemical environment with minimal well-to-well, cell-to-cell, 
or animal-to-animal variation. The protein composition of the extract system can be readily altered 
via addition or depletion of individual components. Wild-type or mutant proteins can be added to 
extracts at precise concentrations to test their effects. Assay times range from only minutes to 
hours, and the option of preparing extracts that do not undergo transcription/translation decreases 
the number of potential mechanisms of action of drug library hits. Importantly, target identification 
is simplified due to the biochemical tractability of extracts. 
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Exactly what is Xenopus egg extract? Xenopus egg extract is essentially highly active 
cytoplasm that can be obtained in large quantities suitable for biochemical studies (King, Peters et 
al. 1995, Verma, Peters et al. 2004). Xenopus egg extract is prepared by a centrifugation step that 
disrupts the plasma membrane and releases the cytoplasmic fraction in an essentially undiluted 
form (Fig. 1). Because Xenopus eggs are maternally loaded with all the necessary components 
needed for early embryogenesis, Xenopus egg extract contains cytoplasmic proteins, organelles, 
amino acids, lipids, and nucleotides at or near physiological levels. The following biological 
processes have been studied in the Xenopus egg extract system: cytoskeletal dynamics, nuclear 
assembly and import, apoptosis, post-translational modifications, ubiquitin metabolism, cell cycle 
progression, and signal transduction pathways (Mitchison and Kirschner 1984, Dabauvalle and 
Scheer 1991, Glotzer, Murray et al. 1991, Murray 1991, Theriot, Rosenblatt et al. 1994, Salic, Lee 
et al. 2000, Verma, Peters et al. 2004, Chan and Forbes 2006, Kornbluth, Yang et al. 2006, Maresca 
and Heald 2006, Shennan 2006, Tutter and Walter 2006). In typical preparations of Xenopus egg 
extract, biochemical pathways remain largely intact and can be readily assayed in high throughput 
screens. Xenopus egg extract can be altered using standard biochemical approaches. Recombinant 
or in vitro-translated proteins can be added to the extract to test the effects of increased 
concentrations of particular components. Alternatively, because Xenopus egg extract retains a high 
capacity for translating mRNAs, synthetic mRNAs can be added to the extract to translate the 
desired proteins to high levels, thereby circumventing the need for generating recombinant 
proteins. For loss of function studies, antibodies can be used to immunodeplete specific proteins. 
Alternatively, dominant-negative versions of proteins can be added either as recombinant proteins 
or as mRNAs. Below, we describe the reconstitution of complex biological pathways using 
Xenopus egg extract. Table 1 lists the pathways that have been successfully screened in Xenopus 
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egg extract to identify small molecule modulators. Table 2 lists small molecule compounds that 
have been validated using Xenopus egg extract. 
Reconstitution of complex biological pathways in Xenopus egg extracts 
Cell cycle 
The Xenopus egg extract system has been particularly valuable in elucidating mechanistic 
details of the cell cycle. A fertilized Xenopus egg undergoes many rounds of synchronous cell 
divisions in the absence of cell growth, thereby subdividing a single-celled egg into a similarly 
sized embryo of ~4,000 cells within the first eight hours of development. Proteins and mRNAs 
required for cell division are maternally loaded into the egg so as to allow cell divisions to take 
place without the need for transcription. In groundbreaking experiments performed over the past 
few decades, Xenopus egg extract has been used to reconstitute major cell cycle events: entry into 
mitosis, cyclin degradation, mitotic spindle assembly, and chromosome segregation.  
 Work by Murray and Kirschner demonstrated that addition of Cyclin B is sufficient to drive 
Xenopus egg extract into mitosis and that fluctuations in Cyclin B levels largely mediate 
progression through the embryonic cell cycle (Murray and Kirschner 1989, Murray, Solomon et 
al. 1989, Glotzer, Murray et al. 1991, Murray 1991). Using this same system, the detailed 
molecular basis for Cyclin B degradation was uncovered (Murray and Kirschner 1989, Murray, 
Solomon et al. 1989, Glotzer, Murray et al. 1991, Murray 1991). Studies in Xenopus egg extract 
identified Cyclin B and Cdk1 as the molecular components of Maturation Promoting Complex 
(Lohka, Hayes et al. 1988). Two decades later, studies in this system were key to formulating a 
biochemical and mathematical description of the mechanism by which Cyclin B and Cdk1 impart 
an oscillatory nature to the cell cycle (Pomerening, Kim et al. 2005).  
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Using this system, ubistatin was identified by King and colleagues as a cell cycle inhibitor 
in a small molecule screen of >100,000 compounds (Verma, Peters et al. 2004). Cyclin B is 
degraded upon exit from mitosis in a process mediated by the Anaphase-Promoting Complex, an 
E3 ubiquitin ligase. For a HTS assay, Cyclin B was fused to luciferase and added to extract. Its 
proteolysis was then monitored to identify compounds that blocked its degradation. Subsequent 
experiments in a purified biochemical system showed that ubistatin inhibited cell cycle progression 
by blocking the binding of ubiquitylated substrates to the proteasome (Verma, Peters et al. 2004). 
Nuclear assembly and disassembly 
 Elucidation of the mechanism underlying nuclear assembly and disassembly has been 
greatly facilitated by the development of an in vitro system using Xenopus egg extract. The nuclear 
membrane serves to physically separate the genomic DNA from the cytoplasm. The nuclear pore 
complex mediates the trafficking of macromolecules between the nucleus and cytoplasm. Xenopus 
egg extract contains large amounts of disassembled nuclear components including an abundance 
of nuclear pores. Pioneering work by Lohka and Masui demonstrated that incubation of chromatin 
with Xenopus egg extract spontaneously induced the formation of a nuclear structure around 
demembranated sperm nuclei (Lohka and Masui 1983, Lohka and Masui 1984). Nuclei formed in 
vitro in this manner are indistinguishable from eukaryotic nuclei observed in cultured cells and 
organisms (as visualized by phase contrast and immunofluorescence microscopy). Using this in 
vitro system, nuclear import activity can be readily measured by assaying for accumulation of 
substrates within the reconstituted nuclei (Newmeyer, Finlay et al. 1986, Finlay, Newmeyer et al. 
1987). Xenopus egg extract was also shown to reconstitute nuclei using purified lamda DNA as 
template (Newport 1987). This breakthrough allowed for identification of discrete intermediates 
in chomatin assembly.  
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 In contrast to interphase extract, which promotes nuclear assembly, mitotic Xenopus egg 
extract promotes nuclear disassembly (Lohka and Masui 1983, Newport and Spann 1987). Mitotic 
Xenopus egg extract can be prepared from unactivated eggs in the presence of a calcium chelator 
or addition of recombinant cCclin B to drive interphase extract into mitosis (Newport 1987, 
Murray and Kirschner 1989). Addition of intact nuclei to mitotic extract results in nuclear envelope 
breakdown and vesicularization, lamin solubilization, and chromosome condensation. Thus, 
Xenopus egg extract represents a powerful biochemical system to nuclear pores (Chan and Forbes 
2006).  
DNA replication and Repair 
Although studies in yeast have provided critical insights into proteins involved in the 
initiation of DNA replication, our understanding of the biochemical mechanisms and temporal 
events of eukaryotic DNA replication has been driven in large part by work using Xenopus egg 
extract. A large stockpile of material that is capable of supporting a rapid and complete round of 
chromosomal DNA replication is present within Xenopus egg extract, thus making it a powerful 
system to study this process. This in vitro system has been used in pioneering studies on the 
initiation of DNA replication (Blow and Laskey 1986). Demembranated sperm chromatin added 
to Xenopus egg extract undergoes a single round of semiconservative DNA replication. DNA is 
replicated efficiently but is only observed upon efficient nuclear assembly (Blow and Sleeman 
1990). Evidence that structural components of the nucleus are essential for replication initiation 
comes from studies in which lamins are immunodepleted; nuclear assembly is not inhibited, but 
the nuclei formed are not capable of initiating DNA replication (Newport, Wilson et al. 1990, 
Meier, Campbell et al. 1991). Subsequent advances have led to the development of modified 
Xenopus egg extract capable of replicating chromosomal DNA in the absence of nuclei (Walter, 
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Sun et al. 1998). Such extract supports the replication of small DNA (e.g. plasmids). This feature 
has made it possible to study the effects of DNA topology and sequence on DNA replication. 
Studies using such modified Xenopus egg extract along with studies using traditional “nuclear 
assembly” egg extract have provided detailed insights into the formation of the pre-replication 
complex and its mechanism of activation (Arias and Walter 2004).  
It is imperative for the survival of an organism that genomic integrity is preserved. To 
accomplish this goal, eukaryotic cells utilize numerous types of DNA damage and replication 
checkpoints. Biochemical studies using Xenopus egg extract have helped to identify the 
components and mechanisms involved in these checkpoints. For example, the functions of key 
regulators of the DNA checkpoint pathways in the mammalian DNA damage response, such as 
ATM and ATR, have been illuminated using Xenopus egg extract (Garner and Costanzo 2009). 
Using the Xenopus egg extract system, Walter and Newport demonstrated that uncoupling of 
MCM helicase (a helicase essential for DNA replication) and DNA polymerase in response to UV 
irradiation is necessary for checkpoint activation (Walter and Newport 2000).  
Microtubule polymerization 
 Xenopus eggs, which are abundant in proteins involved in regulation of microtubules, have 
been instrumental in our understanding of microtubule dynamics (Shirasu, Yonetani et al. 1999). 
Microtubule ends undergo phases of polymerization (“rescue”) and depolymerization 
(“catastrophe”) in a stochastic fashion in a process known as “dynamic instability” that was first 
coined by Mitchison and Kirschner based on their studies of Xenopus egg extract (Mitchison and 
Kirschner 1984). The biochemical tractability of the Xenopus egg extract system has led to the 
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identification of numerous microtubule-associated proteins that modulate microtubule 
polymerization (Desai and Mitchison 1997). 
The ability to reconstruct a complete, functional mitotic spindle in a test tube using 
Xenopus egg extract has been a watershed for the biochemical interrogation of spindle formation 
and function (Desai, Murray et al. 1999). During mitosis, microtubules undergo dramatic 
reorganization to mediate sister-chromatid separation during cell division. Because the cell cycle 
state can be synchronized in Xenopus egg extract, this system has been invaluable in our 
understanding of the role of microtubules in the formation of the mitotic spindle and chromosome 
segregation (Sawin and Mitchison 1991, Hannak and Heald 2006). The addition of fluorescent 
tubulin to Xenopus egg extract made it feasible to perform time-lapse image analysis of the mitotic 
spindle to study its dynamic properties (Sawin and Mitchison 1991, Sawin and Mitchison 1991). 
Using Xenopus egg extract, Rebecca Heald in the lab of Eric Karsenti showed that a bipolar spindle 
can spontaneously assemble around DNA-coated beads, suggesting that bipolarity is an intrinsic 
property of microtubules that form around chromatin during mitosis (Heald, Tournebize et al. 
1996). Finally, taking advantage of the capacity for Xenopus egg extract to support mitotic spindle 
formation, a high throughput screen for inhibitors of mitotic spindle assembly led to the 
identification of the compound diminutol (Wignall, Gray et al. 2004).  
Actin dynamics 
The actin cytoskeleton has been successfully reconstituted using Xenopus egg extract. As 
with microtubules, actin nucleation and the rate of polymerization are regulated by numerous 
actin-binding proteins (Cameron, Giardini et al. 2000). Our understanding of actin dynamics and 
its interacting partners has been advanced by the successful reconstitution of actin in egg extract 
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(Theriot, Rosenblatt et al. 1994, Ma, Cantley et al. 1998, Rohatgi, Ho et al. 2000). Listeria 
monocytogenes is an intracellular bacterium that utilizes an actin-based mechanism in which an 
elongated structure containing actin filaments (“comet tail”) is assembled to propel the bacterium 
within the host cell. Using Xenopus egg extract, Theriot and colleagues were able to observe the 
actin-based motility of Listeria monocytogenes (Theriot, Rosenblatt et al. 1994). Depleting 
Xenopus egg extract of actin depolymerizing factor (ADF)/cofilin (XAC) resulted in increased 
length of the comet tail, demonstrating that XAC is involved in actin filament turnover during 
comet tail formation (Rosenblatt, Agnew et al. 1997).  
Xenopus egg extract is an ideal system to dissect the components of signal transduction 
pathways that regulate the dynamic properties of actin. The actin cytoskeleton is regulated by a 
diverse set of membrane-proximal cues that recruit and activate Wiskott Aldrich Syndrome Protein 
(WASP) family members, which associate with the Arp2/3 complex to initiate the polymerization 
of new actin filaments. Using Xenopus egg extract, Cdc42, a member of the Rho family of 
GTPases, and phosphatidylinositol 4, 5-bisphosphate have been shown to activate the Arp2/3 
complex through WASP to induce actin assembly (Ma, Cantley et al. 1998, Rohatgi, Ho et al. 
2000). Taking advantage of this system, the Kirschner group purified Toca-1, a member of the 
evolutionarily conserved PCH protein family, from Xenopus egg extract and demonstrated that it 
is required for Cdc42-mediated activation of WASP (Ho, Rohatgi et al. 2004). The fluorescence 
of pyrene-labeled actin monomers increases 20- to 30-fold upon polymerization, and provides a 
fast and quantitative assay for actin polymerization. Taking advantage of this property, an HTS 
was performed in Xenopus egg extract that identified a cyclic peptide (Wiskostatin) that maintains 
WASP in an autoinhibitory state via an allosteric mechanism (Peterson, Lokey et al. 2001).  
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Apoptosis 
 Programmed cell death (apoptosis) has been successfully reconstituted using Xenopus egg 
extract (Deming and Kornbluth 2006). Apoptosis is mediated by the activation of a cascade of 
serine proteases of the caspase family (Spencer and Sorger 2011). These activated caspases 
ultimately impinge on a large number of cellular targets, thereby leading to cell death. In Xenopus 
egg extract, apoptosis occurs spontaneously when the extract is allowed to incubate at room 
temperature for an extended period of time (Newmeyer, Farschon et al. 1994). Alternatively, 
apoptosis can be induced in Xenopus egg extract upon addition of purified cytochrome c to extract 
depleted of the mitochondrial fraction. In such a system, markers of apoptosis (e.g. caspase 
activation, chromatin condensation, and nuclear fragmentation) can be readily monitored. Using 
this system, the Kornbluth group demonstrated a link between decreased nutrient status, caspase 
activation, and apoptotic cell death (Nutt, Margolis et al. 2005). Xenopus egg extract thus 
represents a powerful tool to study apoptosis. 
The Wnt pathway 
Overview of the Wnt pathway 
The Wnt pathway controls many aspects of embryonic development and tissue 
maintenance (Logan and Nusse 2004). Wnt dysregulation leads to various developmental defects 
and has been linked to many types of cancer in humans (Logan and Nusse 2004, Clevers 2006). In 
the absence of the Wnt ligand, cytoplasmic -catenin levels are kept low by the -catenin 
destruction complex, which is composed of Axin, adenomatous polyposis coli (APC), glycogen 
synthase kinase 3 (GSK3), and casein kinase 1 (CK1) (MacDonald, Tamai et al. 2009). Axin is 
a scaffolding protein that brings together the destruction complex components and is the limiting 
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factor in -catenin degradation. CK1 primes -catenin for subsequent phosphorylation by GSK3, 
-catenin for ubiquitin-mediated proteolysis. Wnt signaling is initiated when Wnt 
ligands bind Frizzled receptors (Fz) and the co-receptor, low-density lipoprotein-related receptor 
5/6 (LRP5/6). As a consequence, the -catenin destruction complex is recruited to the plasma 
membrane, and -catenin degradation is inhibited. Cytoplasmic accumulation of -catenin leads 
to its translocation into the nucleus, where it turns on Wnt target gene transcription by activating 
T-cell factor/lymphoid enhancer factor (Tcf/Lef) family proteins. In the absence of -catenin, 
Tcf/Lef acts as a transcriptional repressor when bound to Groucho. In the presence of -catenin, 
Groucho is displaced and Tcf/Lef interacts with other nuclear proteins to initiate efficient 
transcription of Wnt target genes (Daniels and Weis 2005). 
The Wnt pathway is constitutively active in many human cancers, particularly colorectal 
cancer (Kinzler and Vogelstein 1996). In the intestinal epithelial cells of familial adenomatous 
polyposis patients, the APC gene is inactive or defective (Kinzler, Nilbert et al. 1991, Nishisho, 
Nakamura et al. 1991). Consistent with a role for Wnt signaling in transformation of epithelial 
cells, loss of APC in mice also leads to the formation of intestinal polyps (Su, Kinzler et al. 1992). 
Remarkably, over 80% of sporadic colorectal cancers have mutations in APC and 10% in -catenin 
(Kinzler, Nilbert et al. 1991). To date, all of the mutations in the Wnt pathway characterized in 
colorectal cancer lead to abnormal accumulation of -catenin and chronic activation of the Wnt 
pathway. In addition to being the initiating event in colon cancer formation, continual Wnt 
pathway activation is thought to be required for maintenance of late-stage colon cancers (Pinto 
and Clevers 2005). Inhibition of Wnt signaling by RNAi or expression of a dominant-negative 
Tcf/Lef in colon cancer cell lines reduces their growth and reverses the epithelial-mesenchymal 
transition.  
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Aberrant Wnt signaling is also involved in cancers such as hepatocellular carcinoma, 
ovarian cancer, prostate cancer, and Wilms tumor (MacDonald, Tamai et al. 2009). Thus, 
inhibition of Wnt signaling may represent an effective therapeutic modality for the treatment of 
many common human cancers. Currently, there are no small compounds in late clinical trials or in 
clinical use that inhibit the Wnt pathway.  
Use of Xenopus egg extract system for studying the Wnt pathway 
Xenopus embryos have played an important role in our understanding of the Wnt pathway 
and its role in early vertebrate development (Hoppler 2008). The pathway is activated in the dorsal 
side of the embryo, an important step in organizing the tissue axis of the embryo. Ectopic 
expression of Wnt induces a secondary dorsal axis, and inhibition of the pathway reduces 
dorsalization of the embryo (Hoppler 2008). This phenotypic readout is simple and clear, and it 
has been used with great success to study the roles of Wnt components.  
Xenopus egg extract is a biochemically tractable, in vitro system that has been used to to 
reconstitute cytoplasmic aspects of the Wnt pathway (Salic, Lee et al. 2000). The regulated 
degradation of -catenin, which is central to Wnt signaling, has been reconstituted using 
cytoplasmic egg extract. Extract prepared from Xenopus eggs is transcriptionally inactive, which 
is likely due to inaccessibility of the assembled chromatin to RNA polymerase II (Newport and 
Kirschner 1982, Newport and Kirschner 1982, Toyoda and Wolffe 1992, Barton, Madani et al. 
1993). In contrast, Xenopus egg extract has a high capacity for translation and can readily translate 
exogenously added mRNA (Minshull, Blow et al. 1989, Murray and Kirschner 1989, Murray, 
Solomon et al. 1989, Glotzer, Murray et al. 1991, Matthews and Colman 1991, Murray 1991). The 
translational capacity of extract can be inhibited by addition of cycloheximide or by simply freeze-
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thawing the extract (Murray and Kirschner 1989, Murray, Solomon et al. 1989, Glotzer, Murray 
et al. 1991, Murray 1991). Thus, -catenin stability in extract can be directly assessed without 
complications from changes in its steady-state levels (Salic, Lee et al. 2000). 
 In addition, known components of the Wnt pathway, such as Dsh and LRP6, can be added 
as purified proteins directly into the system to effect changes in the kinetics of -catenin 
degradation, thereby allowing for quantitative analysis of the Wnt pathway (Salic, Lee et al. 2000, 
Cselenyi, Jernigan et al. 2008). Using a biochemical approach that involved depleting and 
supplementing various Wnt components in Xenopus egg extract, the regulation of -catenin 
turnover and the role of APC-axin--catenin interactions were examined; these data were used to 
develop a mathematical model of the Wnt pathway (Salic, Lee et al. 2000, Lee, Salic et al. 2003). 
HTS screening of the Wnt pathway using Xenopus extract 
Previous studies have shown that activation of the Wnt pathway promotes degradation of 
Axin and stabilization of -catenin; conversely, inhibition of the Wnt pathway promotes 
stabilization of Axin and turnover of -catenin (Mao, Wang et al. 2001, Lee, Salic et al. 2003, 
Tolwinski, Wehrli et al. 2003, Kofron, Birsoy et al. 2007, Cselenyi, Jernigan et al. 2008). Because 
Axin and -catenin turnover represent independent readouts for Wnt signal transduction, and their 
stabilities are regulated in opposite directions, measuring changes in both of their levels represents 
a powerful approach to monitor Wnt pathway activity. Addition of a recombinant form of the 
intracellular domain of LRP6, which had been previously shown to promote degradation of Axin 
and stabilization of -catenin, resulted in activation of the Wnt pathway (Cselenyi, Jernigan et al. 
2008, Thorne, Hanson et al. 2010).  
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 A high throughput screen using Xenopus egg extract to identify small molecules that inhibit 
the Wnt pathway was recently undertaken (Thorne, Hanson et al. 2010, Thorne, Lafleur et al.). To 
facilitate detection of -catenin and Axin levels in a high throughput format, -catenin and Axin 
proteins were fused to firefly and Renilla luciferase, respectively. The high throughput screen 
identified pyrvinium, an FDA-approved drug, as an inhibitor of the Wnt pathway. Inhibition of the 
Wnt pathway by pyrvinium was validated by in vivo studies (Thorne, Hanson et al. 2010). Injection 
of pyrvinium into developing Xenopus embryos induced ventralization and blocked Xwnt8-
induced secondary axis formation, confirming that the compound was active in an organism. 
Further studies showed that pyrvinium was active in Drosophila and C. elegans, indicating that 
the molecular target of pyrvinium was conserved across phyla (Thorne, Hanson et al. 2010). 
Reconstitution studies using purified components ultimately identified casein kinase 1 (CK1) 
as the cellular target of pyrvinium and suggested that pyrvinium may allosterically activate CK1. 
Further studies have subsequently shown that pyrvinium is biologically active in mouse models 
(Saraswati, Alfaro et al.).  
Future studies of other embryonic signaling pathways using Xenopus egg extract 
The Wnt, Hedgehog, and Notch pathways play critical roles in regulating cell fate during the 
embryonic development of metazoans (Logan and Nusse 2004, Andersson, Sandberg et al. , 
Ingham, Nakano et al.). Not surprisingly, these signaling pathways are required to maintain stem 
renewal and homeostasis in adult organs. Together, these pathways are hypothesized to be 
inappropriately regulated in the vast majority of solid human tumors (Beachy, Karhadkar et al. 
2004, Ranganathan, Weaver et al.). Recent evidence strongly suggests the existence of a 
population of stem cells (cancer stem cells) capable of generating all of the cell types found in a 
given tumor (Dick 2009, Frank, Schatton et al.). Given their roles in stem cell renewal and 
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differentiation, it has been predicted that targeting these three pathways would have a major impact 
on regenerative medicine and cancer therapy. Currently, there are no drugs for general use in the 
clinic that target Wnt, Hedgehog, or Notch signaling pathways.  
There are strong structural and regulatory parallels between Wnt, Hedgehog, and Notch 
signaling pathways (Fig. 2). All three pathways ultimately impinge on a transcription factor so as 
to regulate a program of gene expression that alters cellular behavior and fate. Many of the genes 
regulated by these three pathways are involved in cellular growth and proliferation (Barker and 
Clevers 2006, Katoh and Katoh 2009, Ranganathan, Weaver et al.). For all three pathways, 
proteolysis of a critical transcription factor occurs via the ubiquitin-proteosome system. In the case 
of Wnt and Hedgehog, proteolysis of the transcription factor occurs in the absence of ligand and 
is inhibited in a ligand-dependent manner (Logan and Nusse 2004, Robbins and Hebrok 2007, 
MacDonald, Tamai et al. 2009, Ingham, Nakano et al.). For Notch signaling, proteolysis occurs in 
a ligand-dependent manner to generate Notch intra-cellular domain (NICD), the active 
transcription factor. Growing evidence, however, suggests that ubiquitin-mediated turnover may 
limit the activity of the liberated NICD (Hubbard, Wu et al. 1997, Oberg, Li et al. 2001, Wu, 
Lyapina et al. 2001, Andersson, Sandberg et al.). Thus, as with the Wnt and Hedgehog pathways, 
proteolysis may represent a mechanism for regulating Notch signaling. As described above for the 
Wnt pathway, small molecules that modulate the the turnover of transcription factors that mediated 
Hedgehog and Notch signaling could similarly represent attractive strategies for targeting these 
two pathways. A brief description of the Hedgehog and Notch pathways is given. 
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The Hedgehog pathway 
Hedgehog ligands are synthesized as precursor proteins that undergo autocleavage to 
generate the active ligands. In the absence of Hedgehog, the twelve-transmembrane protein 
Patched (Ptch) represses the activity of the seven-transmembrane protein Smoothened (Smo). 
Binding of Hedgehog to its receptor, Ptch, relieves inhibition of Smo activity by Ptch via a largely 
uncharacterized mechanism. Smo, which is the rate-limiting step in Hedgehog signaling, regulates 
the activity of all known downstream effectors upon binding of Hedgehog to Ptch (Ogden, Ascano 
et al. 2004). Hedgehog signaling ultimately alters the activity and stability of members of the GLI 
family of transcription factors in a manner that is tightly regulated by a large molecular weight 
protein complex (Fig. 2) (Robbins and Hebrok 2007, Ingham, Nakano et al.). The GLI proteins 
subsequently regulate a large number of Hedgehog target genes including Cyclin D1, Myc, and 
Bcl-2 (Katoh and Katoh 2009).   
Dysregulation of the Hedgehog pathway has been implicated in multiple types of human 
solid tumors. GLI1 was initially identified as a gene that is amplified in malignant glioma and was 
subsequently shown to be upregulated in other malignant cancers such as basal cell carcinoma 
(Kinzler, Bigner et al. 1987, Dahmane, Lee et al. 1997, Green, Leigh et al. 1998). Ptch mutations 
have been implicated in basal cell carcimona, in particular Gorlin syndrome, a rare inherited 
disease (Hahn, Wicking et al. 1996, Johnson, Rothman et al. 1996). The most clinically advanced 
drug that targets the Hedgehog pathway, the Smo inhibitor GDC-0449, is currently in clinical trials 
and has been shown to be effective for the treatment of basal cell carcinoma (Rubin and de Sauvage 
2006). Resistance to GDC-0449, however, due to mutations in Smo that block its binding to the 
drug, has been reported (Yauch, Dijkgraaf et al. 2009). Patients with mutations in Smo (or elevated 
GLI) would likely benefit from compounds that target the Hedgehog pathway further downstream.  
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The Notch pathway 
Notch receptors are single-pass type I transmembrane glycoproteins (Kopan and Ilagan 
2009, Andersson, Sandberg et al.). Notch ligands (Delta/Delta-like, Serrate/Jagged, Lag-2) are 
themselves single-pass transmembrane receptors. Thus, activation of the Notch pathway requires 
close juxtaposition of cells. An unusual aspect of Notch signaling is that binding of Notch receptor 
to its ligand induces successive proteolytic events. The first cleavage, dependent on ligand 
activation, is mediated by an ADAM metalloprotease and occurs in the extracellular domain to 
generate a membrane-anchored Notch extracellular truncation (NEXT) fragment (Bozkulak and 
Weinmaster, 2009)(van Tetering et al., 2009). This NEXT fragment is a substrate for a gamma-
secretase, which cleaves the protein within the transmembrane domain. The freed Notch ICD 
(NICD) subsequently translocates into the nucleus to initiate transcription of Notch target genes.  
Blocking gamma secretase activity has been the primary focus for development of 
therapeutics against the Notch pathway, and several gamma secretase inhibitors (GSIs) are in early 
clinical trials (Wolfe 2009). Side effects of GSIs, however, including debilitating diarrhea resulting 
from treatment-induced differentiation of mucus-producing Goblet cells, represent a major hurdle 
for their further development. The carboxy terminus of NICD contains a PEST domain, which 
regulates its intracellular stability. The importance of this sequence is suggested by the 
identification of mutations within this domain in certain Notch-driven tumors (Weng, Ferrando et 
al. 2004, Westhoff, Colaluca et al. 2009). These mutations are predicted to increase NICD steady-
state levels, thereby resulting in enhanced pathway activation. Interestingly, mutations that alter 
NICD stability have been shown to be resistant to the effects of GSIs (O'Neil, Grim et al. 2007). 
This observation suggests that promoting the degradation of NICD may be an alternative strategy 
for inhibiting Notch-driven tumors with stabilizing mutations of NICD. 
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Summary 
Xenopus egg extract represents an attractive system that combines the advantages of a phenotypic 
screen (not limited by preconceived hypothesis as to the appropriate drug target) with the 
tractability of a biochemical approach (more quantitative and reproducible) for high throughput 
screening. As discussed herein, the Xenopus egg extract system has been exploited to reconstitute 
a wide range of complex biological processes. Xenopus egg extract has been successfully used in 
high throughput screens (or further validation) for small molecule modulators of the cell cycle, 
microtubule polymerization, and actin polymerization (Tables 1 and 2).  
 We have previously shown that the Wnt pathway can be reconstituted in Xenopus egg 
extract and successfully screened for small molecular modulators of -catenin degradation. Similar 
to the Wnt pathway, other “embryonic” pathways (e.g. Hedgehog and Notch) play critical roles in 
early metazoan development. A common feature of all three is that proteolysis of key 
transcriptional mediators controls the extent of signaling through the pathway. Thus, as for the 
Wnt pathway, a screening strategy using Xenopus egg extract represents an attractive approach to 
identify small molecule modulators of the Hedgehog and Notch pathways. Evidence for the 
feasibility of such an approach comes from our recent studies showing that the transcriptional 
mediators of the Hedgehog (Gli1) and Notch (NICD) pathways readily undergo robust degradation 
in Xenopus egg extract (Thorne, Lafleur et al.).  
As with any biochemical approach, an obvious drawback to using the Xenopus extract 
system to screen for inhibitors of Wnt, Hedgehog, and Notch pathways is that one cannot screen 
for modulators of cellular morphology. In addition, because one is limited to screening for 
cytoplasmic events of these pathways, it is not feasible to screen for compounds that selectively 
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modulate activation of particular receptor subtypes or other events at the level of the receptor (e.g. 
cell-to-cell communication). Specific transcriptional programs are ultimately initiated upon 
activation of the Wnt, Hedgehog, and Notch signaling pathways. To date, however, a system in 
which transcriptional responses can be readily measured in a high throughput fashion has not been 
developed. Regardless, the roles of Hedgehog and Notch pathways, like the Wnt pathway, have 
been well characterized during Xenopus embryonic development; thus, in vivo validation of 
compounds can also be readily performed using Xenopus embryos. Although we have focused on 
screening for small molecule modulators of pathways in which proteolysis plays a central role, we 
expect that other signaling pathways could similarly be interrogated using Xenopus egg extract.  
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Figures 
 
Figure A.1. Preparation of Xenopus egg extract for HTS screening.  Xenopus females are 
injected with human chorionic gonadotropin to induce egg laying into containers filled with buffer. 
Eggs are collected and the jelly coat removed by treatment with 2% cysteine. The dejellied eggs 
are washed and subjected to a packing spin (~100 x g) to remove excess buffer. The packed eggs 
are then subjected to a crushing spin (>15,000 x g) that separates the crushed egg components into 
three distinct layers: lipid, cytoplasmic, and pigmented granule/yolk. The cytoplasmic layer is 
collected and can be used for biochemical studies or for HTS. Recombinant proteins can be added 
directly to the egg extract; alternatively, if recombinant proteins are not readily available, mRNA 
encoding the desired proteins can be added instead. For the latter, the egg extract must be freshly 
prepared because frozen extract loses its capacity to translate mRNAs. To immunodeplete specific 
proteins from extract, antibodies linked to resin can be added and removed. Finally, a specific 
compound can be added to perturb the signaling pathway followed by screening for other 
compounds that either synergize with it or block its effects. Screen readouts may include 
fluorescence with GFP constructs, luminescence with luciferase constructs, or radioactivity using 
scintillation proximity assays. Microsopic analysis of cellular structures (e.g. mitotic spindle, 
nuclear envelope, chromosomes, etc.) can also be performed in a high throughput manner with 
appropriate imaging analysis software. 
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Figure A.2. Schematic of the Wnt, Hedgehog, and Notch signaling pathways highlighting 
cytoplasmic degradation of key transcriptional mediators.  For Wnt signaling, the 
transcriptional coactivator, -catenin, is degraded in the absence of a Wnt signal, whereas the 
scaffold protein, Axin, is stable. Binding of Wnt ligands to the Frizzled and LRP5/6 coreceptors 
results in inhibition of -catenin degradation whereupon it enters the nucleus. Transcription factors 
such as TCF, BCL9, and Pygopus form a complex with nuclear -catenin that leads to activation 
of a Wnt transcriptional program. In contrast, Axin degradation is stimulated upon Wnt pathway 
activation. Members of the GLI family of transcriptional factors are the mediators of canonical 
Hedgehog (HH) signaling. In the absence of HH, GLI proteins are degraded or converted to a 
lower molecular weight form (GLI-R), which acts as a transcriptional repressor. Proteolysis of 
GLI occurs in a cytoplasmic complex containing several kinases including glycogen synthase 
kinase 3 (GSK3), casein kinase 1 (CK1), and protein kinase A (PKA). The binding of HH to 
its receptor, Patched (Ptch), relieves inhibition of the seven membrane-spanning protein, 
Smoothened (Smo), by Ptch via an unknown mechanism. The uninhibited Smo protein 
subsequently inhibits GLI proteolysis, promoting accumulation of the full-length form and 
subsequent activation of HH target genes. Notch signaling is initiated upon binding of the 
transmembrane Notch protein to the Delta/Serrate/LAG-2 (DSL) family of plasma transmembrane 
ligands present in the membrane of adjacent cells. Binding results in a series of proteolytic 
cleavage events that ultimately release the Notch intracellular domain (NICD) into the cytoplasm 
followed by its translocation into the nucleus. In the absence of NICD, the CBF1/Suppressor of 
Hairless/LAG1 (CSL) family of DNA binding proteins associates with corepressors (CoR) to 
inhibit Notch target gene transcription. Nuclear NICD interacts with CSL and the transcriptional 
coactivator Mastermind (MAML1) to recruit transcriptional coactivators (CoA) to initiate 
transcription of Notch target genes.   
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